InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ordan Mark S, Chief Executive Officer. Officer active across 4 companies, notably MEDNAX, INC.. Aggregated, 18 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €1.6m. History available since 30 August 2021. The latest transaction was filed on 1 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ordan Mark S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
4,450 shares0Common StockSEC:0001628280-26-029468:0
4,450 shares@ US$49.44100.0% of flowCommon StockSEC:0001628280-26-029468:1
23,000 shares@ US$22.4114.4% of flowCommon StockSEC:0001193125-25-322897:0
194,347 shares0Common StockSEC:0000950170-25-081078:0
7,225 shares@ US$14.443.6% of flowCommon StockSEC:0000950170-25-069428:0
5,235 shares0Common StockSEC:0001527166-25-000060:0
27,600 shares@ US$15.3515.3% of flowCommon StockSEC:0000950170-24-127164:0
18,360 shares0Common StockSEC:0000950170-24-058783:0
5,004 shares0Common StockSEC:0000950170-24-053049:0
33,000 shares@ US$13.2615.6% of flowCommon StockSEC:0001209191-23-032592:0
9,463 shares0Common StockSEC:0001209191-23-029512:0
6,238 shares0Common StockSEC:0000899243-23-012101:0
98,932 shares@ US$14.8652.8% of flowCommon StockSEC:0001209191-23-001044:0
22,166 shares@ US$15.4512.7% of flowCommon StockSEC:0001209191-22-058674:0
5,236 shares0Common StockSEC:0000899243-22-016149:0
76,253 shares0Common StockSEC:0001209191-22-015588:0
880 shares0Common Shares of Beneficial InterestSEC:0000034903-22-000002:0
95,000 shares@ US$17.65100.0% of flowCommon StockSEC:0001209191-21-054168:0
18 of 18 declarations
About Ordan Mark S
ORDAN MARK S is Directeur Général. He has 18 filings in total, and across the 18 sampled filings from 2021-08-31 to 2026-05-01, the reported activity consists entirely of sales, totaling EUR 1577692. The top filings concern MEDNAX, INC. on 2021-08-31 for EUR 1421347.40264235 and Pediatrix Medical Group, Inc. on 2023-01-04 for EUR 1379010.924939255.
